Flex Pharma, LLC
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Nov 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 18, 2027The maintenance fee for Electrohydrodynamic Atomization Nozzle Emitting a Liquid Sheet (US 10,562,048) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,992,603 | Coated Devices and Method of Making Coated Devices That Reduce Smooth Muscle Cell Proliferation and Platelet Activity In force · High confidence | In force | High confidence | |
| US 8,992,471 | Coated Devices and Method of Making Coated Devices That Reduce Smooth Muscle Cell Proliferation and Platelet Activity In force · High confidence | In force | High confidence | |
| US 10,562,048 | Electrohydrodynamic Atomization Nozzle Emitting a Liquid Sheet In force · High confidence | In force | High confidence | |
| US 11,389,450 | Amorphous Nilotinib Microparticles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,998,548 | Amorphous Nilotinib Microparticles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,016,861 | Amorphous Nilotinib Microparticles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,029,740 | Amorphous Nilotinib Microparticles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,053,471 | Amorphous Nilotinib Microparticles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,751,950 | Amorphous Nilotinib Microparticles and Uses Thereof In force · Low confidence | In force | Low confidence | |
| US 11,559,485 | Orally Disintegrating Tablet Comprising Amorphous Solid Dispersion of Nilotinib In force · High confidence | In force | High confidence |
Also on record, not counted in the 12: 4 patents in force now held by others · 9 lapsed for an unpaid fee · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded